Viatris (VTRS)
(Delayed Data from NSDQ)
$10.89 USD
-0.15 (-1.36%)
Updated Feb 4, 2025 04:00 PM ET
After-Market: $10.88 -0.01 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth B Momentum A VGM
Viatris (VTRS) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $13.17 | $15.00 | $12.00 | 19.29% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by six analysts, the average price target for Viatris comes to $13.17. The forecasts range from a low of $12.00 to a high of $15.00. The average price target represents an increase of 19.29% from the last closing price of $11.04.
Analyst Price Targets (6 )
Broker Rating
Viatris currently has an average brokerage recommendation (ABR) of 3.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 3.14 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, one is Strong Buy, representing 14.29% of all recommendations. A month ago, Strong Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 |
| ABR | 3.14 | 3.14 | 3.14 | 3.17 | 3.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 1/7/2025 | Argus Research Corp. | Jasper Hellweg | Hold | Hold |
| 11/8/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
| 8/15/2024 | UBS | Ashwani Verma | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 3.14 |
| ABR (Last week) | 3.14 |
| # of Recs in ABR | 7 |
| Average Target Price | $13.17 |
| LT Growth Rate | NA |
| Industry | Medical Services |
| Industry Rank by ABR | 158 of 251 |
| Current Quarter EPS Est: | 0.57 |
VTRS FAQs
Viatris Inc. (VTRS) currently has an average brokerage recommendation (ABR) of 3.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Viatris Inc. (VTRS) is $13.17. The current on short-term price targets is based on 6 reports.
The forecasts for Viatris Inc. (VTRS) range from a low of $12 to a high of $15. The average price target represents a increase of $19.29 from the last closing price of $11.04.
The current UPSIDE for Viatris Inc. (VTRS) is 19.29%
Based on short-term price targets offered by six analysts, the average price target for Viatris comes to $13.17. The forecasts range from a low of $12.00 to a high of $15.00. The average price target represents an increase of 19.29% from the last closing price of $11.04.